| Literature DB >> 27381437 |
Qing Tang1, Kang Yin1, Hongliang Qian1, Youwen Zhao1, Wen Wang1, Shan-Ho Chou2, Yang Fu1, Jin He1,3.
Abstract
Cyclic di-GMP is a ubiquitous second messenger that regulates diverse cellular processes in bacteria by binding to various protein or riboswitch effectors. In Bacillus thuringiensis BMB171, a c-di-GMP riboswitch termed Bc2 RNA resides in the 5'-untranslated region (5'-UTR) of an mRNA that encodes a collagen adhesion protein (Cap). The expression of cap was strongly repressed in parent strain BMB171 because of the presence of Bc2 RNA but was significantly promoted in the Bc2 RNA markerless deletion mutant. Bc2 RNA acts as a genetic "on" switch, which forms an anti-terminator structure to promote cap read-through transcription upon c-di-GMP binding. As a result, cap transcription was de-repressed under high c-di-GMP levels. Therefore, Bc2 RNA regulates cap expression using a repression/de-repression model. Bc2 RNA-regulated Cap was also found to be tightly associated with motility, aggregation, exopolysaccharide secretion, biofilm formation, and virulence of B. thuringiensis BMB171 against its host insect Helicoverpa armigera.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27381437 PMCID: PMC4933901 DOI: 10.1038/srep28807
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Scheme of Bc2 RNA secondary structure and multiple sequence alignments of Bc2 RNAs.
(a) Schematic representation of full length and terminated cap transcripts. TSSs (+1) are labeled by bent arrows. AUG is the start code. (b) Sequence alignments of Bc2 RNAs from B. thuringiensis and B. cereus with Vc2 RNA. White letters shaded in magenta, orange, green and black denote the conserved nucleotides of A, G, and C and U, respectively. The predicted c-di-GMP binding sites were highlighted by red stars, with the consensus sequences of Bc2 RNAs depicted below the alignments. The aptamer region and expression platform were underlined by blue and brown lines, respectively.
Figure 2Binding of c-di-GMP to Bc2 RNA riboswitch enhances transcription read-through of cap gene.
(a) The relative expression levels of the 5′-UTR of cap in comparison with the complete cap gene by qPCR analyses in the BMB171 strain. (b) The differential expression levels of cap in the ΔBc2 and BMB171 strain by qPCR. Expression of gapdh gene was served as a negative control. (c) Products of in vitro transcription of DNA templates coding for the wild type (WT) and substitution mutant (A11T) riboswitches. The A11T mutant carries a single A to T mutation in the c-di-GMP binding pocket. FL and T denote full length and terminated transcripts, respectively. (d) The predicted secondary structures of Bc2 RNA in the absence and presence of c-di-GMP. Nucleotides predicted to bind to c-di-GMP are highlighted in red, and nucleotides predicted to form the terminator hairpin in the absence of c-di-GMP are highlighted in olive. The coding sequence of cap is boxed. Error bars depict SD of data from three independent experiments. ***P < 0.001.
Figure 3High levels of intracellular c-di-GMP promote cap expression in B. thuringiensis.
(a) Different intracellular c-di-GMP concentrations of the Δ2dgc, Δ3pde and BMB171 strains as determined by LC-MS/MS. (b) qPCR analyses of differential transcription profiles of cap in the Δ2dgc and Δ3pde mutants in comparison with the parent strain BMB171. (c) β-galactosidase activity analyses for B. thuringiensis strains carrying the Pcap-lacZ, PcapΔ-lacZ or promoterless Pnull-lacZ transcriptional fusion plasmids. (d) β-galactosidase activity analyses for B. thuringiensis strains carrying either Pcap-lacZ or Pcap-lacZ site-mutants or promoterless Pnull-lacZ transcriptional fusion plasmids. (e) Model showing proposed regulation of cap transcription by Bc2 RNA. Error bars depict SD of data from three independent experiments. ***P < 0.001; **P < 0.01; *P < 0.05.
Figure 4Bc2 RNA-regulated Cap decreases motility and increases EPS formation of B. thuringiensis.
(a) Motility assay of ΔBc2, Δcap and BMB171 on LB plate containing 1.5% agar or swimming plate containing 0.3% agar. (b) Congo red binding assay. Cells were grown on LB agar supplemented with 1 mg/mL Congo red dye at 28 °C for 24 h. (c) Quantification of secreted EPS. (d) SEM imaging of bacteria mounted on microscope cover glasses. The extracellular matrix is indicated by arrows. Error bars depict SD of data from three independent experiments. **P < 0.01; *P < 0.05.
Figure 5Excessive Cap leads to decreasing biofilm formation and increasing aggregation rate of B. thuringiensis.
(a) Cell aggregation assay. Mid-logarithmic cultures grown in LB medium were divided into two groups. One group was directly applied for static incubation (Fig. 5a, left). The other was washed with PBS and re-suspended in the LB medium before static incubation (Fig. 5a, right). The interfaces of cell pellets and supernatant were indicated by white lines. (b) Representative photographs of biofilm formation assays for the ΔBc2, Δcap and BMB171 strains in glass bottles. Biofilm at the air-liquid-interface of the culture medium is indicated by arrows. (c) Quantification of biofilm formation by CV stain measured by UV spectrophotometer at 595 nm. Error bars depict SD of data from three independent experiments. *P < 0.05.
Figure 6Cap and biofilm formation display synergistic effect on B. thuringiensis virulence.
(a) Survival rates of H. armigera larvae fed with ΔBc2 RNA, Δcap and BMB171 strains. (b) Biomass of survived H. armigera larvae fed with bacteria for seven days. (c) Photographs of survived H. armigera larvae. All experiments were repeated at least three times. ***P < 0.001.
Plasmids and bacteria used in this study.
| Plasmids and bacteria | Relevant characteristics | Purposes | Origins |
|---|---|---|---|
| pHT1K | β-galactosidase assays | Lab stock | |
| P | pHT1K carrying the promoter region of | β-galactosidase assays | This work |
| P | pHT1K carrying the promoter region of | β-galactosidase assays | This work |
| Pnull- | pHT1K carrying the promoterless | β-galactosidase assays | This work |
| pSS1827 | Helper plasmid for conjugative transfer; Amp | gene-knockout | 53 |
| pRP1028 | Temperature sensitive suicide plasmid, Ampr Ermr, containing | gene-knockout | 53 |
| pSS4332 | gene-knockout | 53 | |
| pRP1028-Bc2UD | Intermediate vector in gene-knockout experiments | gene-knockout | This work |
| pRP1028- | Intermediate vector in gene-knockout experiments | gene-knockout | This work |
| cloning host | Lab stock | ||
| BMB171 | 35 | ||
| Δ | In-frame deletions of | unpublished | |
| Δ | In-frame deletions of | unpublished | |
| ΔBc2 | In-frame deletion of Bc2 DNA derived from BMB171 | This work | |
| Δ | In-frame deletion of | This work | |
| BMB171/P | BMB171 strain carrying the P | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| BMB171/P | BMB171 strain carrying the P | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| BMB171/Pnull- | BMB171 strain carrying the Pnull- | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| BMB171/ P | BMB171 strain carrying the P | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| BMB171/ P | BMB171 strain carrying the P | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| BMB171/ P | BMB171 strain carrying the P | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |
| Δ | Δ | β-galactosidase assays | This work |